Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Automated Calculation of Alberta Stroke Program Early CT Score.

Albers GW, Wald MJ, Mlynash M, Endres J, Bammer R, Straka M, Maier A, Hinson HE, Sheth KN, Taylor Kimberly W, Molyneaux BJ.

Stroke. 2019 Sep 10:STROKEAHA119026430. doi: 10.1161/STROKEAHA.119.026430. [Epub ahead of print]

PMID:
31500555
2.

Acute Ischemic Stroke with Vessel Occlusion-Prevalence and Thrombectomy Eligibility at a Comprehensive Stroke Center.

Desai SM, Starr M, Molyneaux BJ, Rocha M, Jovin TG, Jadhav AP.

J Stroke Cerebrovasc Dis. 2019 Aug 10:104315. doi: 10.1016/j.jstrokecerebrovasdis.2019.104315. [Epub ahead of print]

PMID:
31409537
3.

A Novel Na+-K+-Cl- Cotransporter 1 Inhibitor STS66* Reduces Brain Damage in Mice After Ischemic Stroke.

Huang H, Bhuiyan MIH, Jiang T, Song S, Shankar S, Taheri T, Li E, Schreppel P, Hintersteininger M, Yang SS, Lin SH, Molyneaux BJ, Zhang Z, Erker T, Sun D.

Stroke. 2019 Apr;50(4):1021-1025. doi: 10.1161/STROKEAHA.118.024287.

PMID:
30862257
4.

Differential association of subtypes of epileptiform activity with outcome after cardiac arrest.

Faro J, Coppler PJ, Dezfulian C, Baldwin M, Molyneaux BJ, Urban A, Rittenberger JC, Callaway CW, Elmer J; Pittsburgh Post-Cardiac Arrest Service.

Resuscitation. 2019 Mar;136:138-145. doi: 10.1016/j.resuscitation.2018.11.022. Epub 2018 Dec 23.

PMID:
30586605
5.

Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial.

Kimberly WT, Bevers MB, von Kummer R, Demchuk AM, Romero JM, Elm JJ, Hinson HE, Molyneaux BJ, Simard JM, Sheth KN.

Neurology. 2018 Dec 4;91(23):e2163-e2169. doi: 10.1212/WNL.0000000000006618. Epub 2018 Nov 16.

PMID:
30446594
6.

Care of the Post-Thrombectomy Patient.

Jadhav AP, Molyneaux BJ, Hill MD, Jovin TG.

Stroke. 2018 Nov;49(11):2801-2807. doi: 10.1161/STROKEAHA.118.021640. No abstract available.

PMID:
30355218
7.

Laterality is an Independent Predictor of Endovascular Thrombectomy in Patients With Low National Institute of Health Stroke Scale.

Desai SM, Rocha M, Starr M, Molyneaux BJ, Kenmuir CL, Gross BA, Jankowitz BT, Jovin TG, Jadhav AP.

J Stroke Cerebrovasc Dis. 2018 Nov;27(11):3172-3176. doi: 10.1016/j.jstrokecerebrovasdis.2018.07.016. Epub 2018 Aug 2.

PMID:
30078759
8.

Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis.

Sheth KN, Petersen NH, Cheung K, Elm JJ, Hinson HE, Molyneaux BJ, Beslow LA, Sze GK, Simard JM, Kimberly WT.

Stroke. 2018 Jun;49(6):1457-1463. doi: 10.1161/STROKEAHA.117.020365. Epub 2018 May 22.

9.

Thrombectomy 6-24 hours after stroke in trial ineligible patients.

Desai SM, Rocha M, Molyneaux BJ, Starr M, Kenmuir CL, Gross BA, Jankowitz BT, Jovin TG, Jadhav AP.

J Neurointerv Surg. 2018 Nov;10(11):1033-1037. doi: 10.1136/neurintsurg-2018-013915. Epub 2018 May 17.

PMID:
29773716
10.

Glibenclamide Produces Region-Dependent Effects on Cerebral Edema in a Combined Injury Model of Traumatic Brain Injury and Hemorrhagic Shock in Mice.

Jha RM, Molyneaux BJ, Jackson TC, Wallisch JS, Park SY, Poloyac S, Vagni VA, Janesko-Feldman KL, Hoshitsuki K, Minnigh MB, Kochanek PM.

J Neurotrauma. 2018 Sep 1;35(17):2125-2135. doi: 10.1089/neu.2016.4696. Epub 2018 Jun 6.

11.

Eligibility for Endovascular Trial Enrollment in the 6- to 24-Hour Time Window: Analysis of a Single Comprehensive Stroke Center.

Jadhav AP, Desai SM, Kenmuir CL, Rocha M, Starr MT, Molyneaux BJ, Gross BA, Jankowitz BT, Jovin TG.

Stroke. 2018 Apr;49(4):1015-1017. doi: 10.1161/STROKEAHA.117.020273. Epub 2018 Mar 16.

PMID:
29581344
12.

Interfacility Transfer Directly to the Neuroangiography Suite in Acute Ischemic Stroke Patients Undergoing Thrombectomy.

Jadhav AP, Kenmuir CL, Aghaebrahim A, Limaye K, Wechsler LR, Hammer MD, Starr MT, Molyneaux BJ, Rocha M, Guyette FX, Martin-Gill C, Ducruet AF, Gross BA, Jankowitz BT, Jovin TG.

Stroke. 2017 Jul;48(7):1884-1889. doi: 10.1161/STROKEAHA.117.016946. Epub 2017 May 23.

PMID:
28536177
13.

Early decompressive craniectomy for malignant cerebral infarction: Meta-analysis and clinical decision algorithm.

Streib CD, Hartman LM, Molyneaux BJ.

Neurol Clin Pract. 2016 Oct;6(5):433-443. Review.

14.

Sulfonylurea Receptor-1: A Novel Biomarker for Cerebral Edema in Severe Traumatic Brain Injury.

Jha RM, Puccio AM, Chou SH, Chang CH, Wallisch JS, Molyneaux BJ, Zusman BE, Shutter LA, Poloyac SM, Janesko-Feldman KL, Okonkwo DO, Kochanek PM.

Crit Care Med. 2017 Mar;45(3):e255-e264. doi: 10.1097/CCM.0000000000002079.

15.

Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial.

Sheth KN, Elm JJ, Molyneaux BJ, Hinson H, Beslow LA, Sze GK, Ostwaldt AC, Del Zoppo GJ, Simard JM, Jacobson S, Kimberly WT.

Lancet Neurol. 2016 Oct;15(11):1160-9. doi: 10.1016/S1474-4422(16)30196-X. Epub 2016 Aug 23.

PMID:
27567243
16.

Clinically distinct electroencephalographic phenotypes of early myoclonus after cardiac arrest.

Elmer J, Rittenberger JC, Faro J, Molyneaux BJ, Popescu A, Callaway CW, Baldwin M; Pittsburgh Post-Cardiac Arrest Service.

Ann Neurol. 2016 Aug;80(2):175-84. doi: 10.1002/ana.24697. Epub 2016 Jun 28.

17.

Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.

Rivosecchi RM, Durkin J, Okonkwo DO, Molyneaux BJ.

Neurocrit Care. 2016 Dec;25(3):359-364.

PMID:
27076286
18.

Reduction of aberrant NF-κB signalling ameliorates Rett syndrome phenotypes in Mecp2-null mice.

Kishi N, MacDonald JL, Ye J, Molyneaux BJ, Azim E, Macklis JD.

Nat Commun. 2016 Jan 29;7:10520. doi: 10.1038/ncomms10520.

19.

Dexmedetomidine Reduces Shivering during Mild Hypothermia in Waking Subjects.

Callaway CW, Elmer J, Guyette FX, Molyneaux BJ, Anderson KB, Empey PE, Gerstel SJ, Holquist K, Repine MJ, Rittenberger JC.

PLoS One. 2015 Aug 3;10(8):e0129709. doi: 10.1371/journal.pone.0129709. eCollection 2015.

20.

DeCoN: genome-wide analysis of in vivo transcriptional dynamics during pyramidal neuron fate selection in neocortex.

Molyneaux BJ, Goff LA, Brettler AC, Chen HH, Hrvatin S, Rinn JL, Arlotta P.

Neuron. 2015 Jan 21;85(2):275-288. doi: 10.1016/j.neuron.2014.12.024. Epub 2014 Dec 31. Erratum in: Neuron. 2016 Jan 6;89(1):235.

21.

Reversible cerebral vasoconstriction syndrome following carotid stenting.

Aghaebrahim A, Jadhav AP, Saeed Y, Totoraitis R, Jankowitz BT, Jovin TG, Molyneaux BJ.

Neurology. 2014 Aug 5;83(6):570-1. doi: 10.1212/WNL.0000000000000677. No abstract available.

PMID:
25092927
22.

Gene co-regulation by Fezf2 selects neurotransmitter identity and connectivity of corticospinal neurons.

Lodato S, Molyneaux BJ, Zuccaro E, Goff LA, Chen HH, Yuan W, Meleski A, Takahashi E, Mahony S, Rinn JL, Gifford DK, Arlotta P.

Nat Neurosci. 2014 Aug;17(8):1046-54. doi: 10.1038/nn.3757. Epub 2014 Jul 6.

23.

Novel subtype-specific genes identify distinct subpopulations of callosal projection neurons.

Molyneaux BJ, Arlotta P, Fame RM, MacDonald JL, MacQuarrie KL, Macklis JD.

J Neurosci. 2009 Sep 30;29(39):12343-54. doi: 10.1523/JNEUROSCI.6108-08.2009.

24.

Bhlhb5 regulates the postmitotic acquisition of area identities in layers II-V of the developing neocortex.

Joshi PS, Molyneaux BJ, Feng L, Xie X, Macklis JD, Gan L.

Neuron. 2008 Oct 23;60(2):258-72. doi: 10.1016/j.neuron.2008.08.006.

25.

Molecular development of corticospinal motor neuron circuitry.

Molyneaux BJ, Arlotta P, Macklis JD.

Novartis Found Symp. 2007;288:3-15; discussion 15-20, 96-8. Review.

PMID:
18494249
26.

SOX5 controls the sequential generation of distinct corticofugal neuron subtypes.

Lai T, Jabaudon D, Molyneaux BJ, Azim E, Arlotta P, Menezes JR, Macklis JD.

Neuron. 2008 Jan 24;57(2):232-47. doi: 10.1016/j.neuron.2007.12.023.

27.

Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum.

Arlotta P, Molyneaux BJ, Jabaudon D, Yoshida Y, Macklis JD.

J Neurosci. 2008 Jan 16;28(3):622-32. doi: 10.1523/JNEUROSCI.2986-07.2008.

28.

Neuronal subtype specification in the cerebral cortex.

Molyneaux BJ, Arlotta P, Menezes JR, Macklis JD.

Nat Rev Neurosci. 2007 Jun;8(6):427-37. Review.

PMID:
17514196
29.

Fezl is required for the birth and specification of corticospinal motor neurons.

Molyneaux BJ, Arlotta P, Hirata T, Hibi M, Macklis JD.

Neuron. 2005 Sep 15;47(6):817-31.

30.

Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo.

Arlotta P, Molyneaux BJ, Chen J, Inoue J, Kominami R, Macklis JD.

Neuron. 2005 Jan 20;45(2):207-21.

31.
32.

Sequence and phylogenetic analysis of squid myosin-V: a vesicle motor in nerve cells.

Molyneaux BJ, Mulcahey MK, Stafford P, Langford GM.

Cell Motil Cytoskeleton. 2000 Jun;46(2):108-15.

PMID:
10891856
33.

Myosin V in the brain: mutations lead to neurological defects.

Langford GM, Molyneaux BJ.

Brain Res Brain Res Rev. 1998 Nov;28(1-2):1-8. Review. No abstract available.

PMID:
9795099
34.

Transport of ER vesicles on actin filaments in neurons by myosin V.

Tabb JS, Molyneaux BJ, Cohen DL, Kuznetsov SA, Langford GM.

J Cell Sci. 1998 Nov;111 ( Pt 21):3221-34.

35.

Characterization of antibodies to the head and tail domains of squid brain myosin V.

Molyneaux BJ, Langford GM.

Biol Bull. 1997 Oct;193(2):222-3. No abstract available.

PMID:
9390390

Supplemental Content

Loading ...
Support Center